Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Vivid Pioneer Ultrasound System

Active

75N98026Q01028 Federal

Response Deadline09/07/2026, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health Nhlbi, under the Department of Health and Human Services, is issuing a presolicitation notice for the procurement of a Vivid Pioneer Ultrasound System. This requirement is categorized under NAICS code 325412 and will be performed in Bethesda, Maryland. Interested parties must submit their responses by September 7, 2026, at 4:00 PM. The primary point of contact for this solicitation is Noelle Decenzo, who can be reached via email or phone for further inquiries regarding the statement of need.

General Info

NIH seeks a Vivid Pioneer Ultrasound System in Bethesda, MD by September 7, 2026.

Agency

Department Of Health And Human Services → National Institutes Of Health NhlbiView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

MD, 20892, USA

Set-Aside

NONE

Documents

(2)

GE Vivid Pioneer Ultrasound System Statement of Need

PDF•sow

75N98026Q01028 Notice of Intent to Sole Source – Vivid Pioneer Ultrasound

PDF•presolicitation

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhasePresolicitation

PostedAug 31

Presolicitation

Response DeadlineSep 7

Submission deadline

Response Deadline

09/07/2026, 04:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health Nhlbi

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health Nhlbi

View Agency Profile

Office AddressBETHESDA, MD, 20892, USA

Contacts

DECENZO NOELLE K

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

Please see the attached Notice of Intent and Statement of Need for details.

Similar Contracts

Same NAICS industry code

6505--FDG Radiopharmaceutical

Solicitation # 36C24426Q0900

244-NETWORK Contract Office 4 (36C244)

POSTED

about 13 hours ago

DEADLINE

Supply of FDA-Regulated Medical Dye Solution (Plastic L)The Department of Defense, through the Medical Supply Chain MD Surg FSF, is seeking a subcontractor for the manufacture and delivery of three pints of FDA-regulated Plastic L dye solution. The supplier must ensure the product is compliant with current Good Manufacturing Practices, specific shelf-life requirements, and federal medical packaging standards. This subcontract opportunity falls under NAICS code 325412 and is designated for performance at APO 09227. Interested parties must submit their responses by September 8, 2026, following the posting date of August 31, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Abbott BinaxNOW COVID-19 Antigen Test KitsThis subcontract opportunity with the Department of Defense, specifically the Medical Supply Chain MD Surg FSF, involves the supply of Abbott BinaxNOW COVID-19 Antigen test kits. These kits are intended for at-home, over-the-counter use and must strictly adhere to FDA regulations, as well as specific packaging, labeling, and domestic content requirements. The procurement is categorized under NAICS code 325412. The response deadline for this requirement is September 8, 2026, with the place of performance located at FPO 96675-9600.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Pharmaceutical Manufacturer for Citalopram Hydrobromide TabletsThis subcontract involves the manufacture and supply of Citalopram Hydrobromide Tablets for the Department of Defense, specifically under the Medical Supply Chain Pharm FSA. The contractor must ensure all products are compliant with FDA and USP regulations, as well as military packaging standards per MIL-STD-2073-1E, for National Stock Number 6505015054632. The performance of this contract is located at Fort Stewart, Georgia. Interested parties must submit their responses by September 8, 2026, following the posting date of August 31, 2026. The project falls under NAICS code 325412 for pharmaceutical manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Topical Analgesic Gel Manufacturing and SupplyThis subcontract involves the full-scale manufacturing, quality control, packaging, and supply of topical analgesic gel, identified by NSN 6505-01-658-7643. The project requires strict compliance with military and hazardous materials regulations to ensure the product meets all necessary safety and performance standards. The contract is issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with the place of performance located at Fort Riley, ZIP code 66442-0000. Under NAICS code 325412, the solicitation was posted on August 31, 2026, with a response deadline of September 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Domestic Sourcing of Raw Materials and ComponentsThis subcontract, titled Domestic Sourcing of Raw Materials and Components, is issued by the Department of Defense under the Medical Supply Chain MD Surg FSF. The contract focuses on the procurement of U.S.-sourced raw materials, specifically sterile gauze, burn ointments, gloves, and packaging films. All supplied materials must strictly comply with the Buy American and Berry Amendment requirements to ensure domestic sourcing. The place of performance for this contract is located at Fort Bliss, Texas. Interested parties must submit their responses by the deadline of September 8, 2026. The procurement falls under NAICS code 325412 and is managed through the DLA DIBBS system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Pharmaceutical Manufacturing – Albendazole Tablets, USPThis subcontract through the Department of Defense Medical Supply Chain Pharma FSA involves the manufacture of prescription-grade Albendazole tablets. The selected provider must ensure all products meet USP standards, with responsibilities encompassing formulation, compression, quality control, and the provision of detailed batch documentation. The project is categorized under NAICS code 325412 and will be performed at Fort Bragg, zip code 28310. Interested parties must submit their responses by September 8, 2026, following the posting date of August 31, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

INSECT REPELLENT SPRAY

Solicitation # SPE2DP-26-T-4797

This contract is a solicitation from the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of 35 units of a non-DEET insect repellent spray. The required product must be 100 percent biodegradable, feature a citrus scent, and be provided in 2 ounce containers. Delivery is required within 20 days after the order is placed, with the place of performance located at APO 96338-5011. Compliance with specific technical and quality standards is mandatory, including DLA packaging requirements and Medical Marking Standard No. 1. Because the item is classified as hazardous material, the supplier must provide a current Material Safety Data Sheet to the DLA electronic mailbox and include a physical copy of the MSDS with every shipment. All packaging must adhere to 49 CFR and ICAO technical regulations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ENROFLOXACIN TABLETS

Solicitation # SPE2DP-26-T-4808

This contract is for the procurement of Enrofloxacin tablets, a broad-spectrum antibacterial medication for veterinary use in dogs and cats. The tablets have a 7 percent concentration of 68 mg and are supplied in bottles containing 250 tablets each. The item must be stored at controlled room temperature and adheres to a non-extendable shelf life of 36 months. The order consists of one bottle under contract SPE2DP-26-T-4808, with delivery required within five days. The product is regulated by the FDA and must comply with DLA packaging requirements and Medical Marking Standard No. 1. Delivery is set as FOB destination, with inspection and acceptance occurring at the destination point.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJECT

Solicitation # SPE2DP-26-T-4816

This contract is for the procurement of Sodium Chloride 0.9% Injection, USP 500 ML, with a unit of issue consisting of 24 units per package. The item is regulated by the FDA and must adhere to Medical Marking Standard No. 1 and DLA packaging requirements. A critical shelf-life requirement of 24 months applies, and the product must be delivered in suitable sealed unit containers within a commercial exterior shipping container. The agreement specifies that mercury or mercury-containing compounds shall not be intentionally added to the supplies. Delivery is set as FOB Destination with an inspection and acceptance point also at the destination, requiring delivery within 20 days. The procurement is managed by the Department of Defense Medical Supply Chain Pharma FSA for performance at Fort Bliss, Texas.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

FERRIC SUBSULFATE SOLU

Solicitation # SPE2DP-26-T-4812

This contract is for the procurement of Ferric Subsulfate Solution, Monsels, supplied in packages of 12 bottles, each containing 8 ml. The solution is intended for direct application to surgical sites following the excision of diseased tissue. Strict storage prohibitions apply, as the material must not be stored in aluminum, carbon steel, copper, copper alloys, zinc, or nickel. The item has a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. The order consists of three packages to be delivered FOB destination to Joint Base Charleston, South Carolina, within 20 days. All materials must be marked according to Medical Marking Standard No. 1 and packaged in sealed unit containers to prevent damage. The contract specifies that shipping must be conducted via traceable means, explicitly prohibiting the use of parcel post. Compliance with DLA packaging requirements and specific technical quality standards is mandatory for the fulfillment of this acquisition.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VECURONIUM BROMIDE FOR

Solicitation # SPE2DP-26-T-4814

This contract is for the procurement of Vecuronium Bromide for Injection, provided as a freeze-dried powder with 10mg of active ingredient per vial. The unit of issue is a package of 10 vials, and the product must be stored at 20 to 25 degrees Celsius and protected from light. The total shelf life is 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. The agreement specifies delivery to Fort Bragg, North Carolina, with a delivery timeframe of five days. Packaging must adhere to DLA and commercial standards, including Medical Marking Standard No. 1 and ASTM D3951, ensuring items are sealed and protected from damage. Shipping must be conducted via the fastest traceable means, excluding parcel post, and must comply with specific DLA packaging and palletization requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nhlbi

Same awarding agency

Clinical Division Genetic Testing and Next Generation Sequencing Services for Active Clinical Protocols- bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and related hematologic disorders

Solicitation # 75N98026Q01002

The National Institutes of Health NHLBI is seeking genetic testing and next generation sequencing services to support active clinical protocols. This effort focuses on the analysis of bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and other related hematologic disorders. This presolicitation, identified by solicitation number 75N98026Q01002, falls under NAICS code 622110. The performance of these services will take place in Bethesda, Maryland, with a response deadline set for September 8, 2026. Interested parties should contact Noelle K. Decenzo for further information.

General Medical and Surgical Hospitals

POSTED

about 13 hours ago

DEADLINE

Odyssey® M multimodal imaging system

Solicitation # 75N98026Q01045

The National Institutes of Health Nhlbi, under the Department of Health and Human Services, is seeking a provider for the Odyssey M multimodal imaging system. This presolicitation opportunity, identified by solicitation number 75N98026Q01045, falls under NAICS code 334516 and will be performed in Bethesda, Maryland. Interested parties must submit their responses by September 8, 2026, at 4:00 PM. The primary point of contact for this requirement is Noelle K. Decenzo, who can be reached via email or phone for further inquiries regarding the statement of need.

Analytical Laboratory Instrument Manufacturing

POSTED

about 13 hours ago

DEADLINE

Off Hours Specimen Processing Service

Solicitation # 75N98026Q01087

The National Institutes of Health NHLBI, under the Department of Health and Human Services, has issued a notice of intent for a sole source purchase order regarding Off Hours Specimen Processing Services. This presolicitation, identified by solicitation number 75N98026Q01087, falls under NAICS code 621511 and is not subject to any specific set-aside restrictions. The opportunity was posted on August 31, 2026, with a response deadline of September 7, 2026, at 2:00 PM. Primary coordination for this requirement is managed by James E. Hawkins, with Lynn M. Furtaw serving as the secondary point of contact. The contracting office is located in Bethesda, Maryland.

Medical Laboratories

POSTED

DEADLINE

Supply of Laboratory Reagents and Consumables for PBMC Processing

Other Chemical and Allied Products Merchant Wholesalers

POSTED

DEADLINE

Logistics and Cold Chain Transport of Biospecimens

All Other Support Activities for Transportation

POSTED

DEADLINE

De-Identified Clinical Data Management and Secure Transfer

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

DEADLINE

Collection of De-Identified PBMC Biospecimens

Medical Laboratories

POSTED

DEADLINE

Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf

Solicitation # 75N98026Q01067

This special notice, issued by the National Institutes of Health under the Department of Health and Human Services, focuses on research regarding the therapeutic role of soluble adenylyl cyclase inhibition in reducing inflammatory vascular remodeling associated with pulmonary arterial hypertension. The project is managed by the NHLBI office located in Bethesda, Maryland, and falls under the NAICS code 621511 for medical laboratories. The solicitation, identified by number 75N98026Q01067, was posted on August 28, 2026, with a response deadline of September 4, 2026. Natalie E. Bruning serves as the primary point of contact for this opportunity.

Medical Laboratories

POSTED

DEADLINE

Supply of xGen 2S Plus DNA Library Prep KitsThis subcontract opportunity with the National Institutes of Health NHLBI under the Department of Health and Human Services involves the procurement of xGen 2S Plus DNA Library Prep Kits, specifically IDT Catalog No. 10009878. These kits are required for next-generation sequencing within a validated research workflow dedicated to transplant patient genomics. To ensure quality and compliance, the supplies must be provided directly by IDT or through an authorized channel. The solicitation was posted on August 26, 2026, with a response deadline of September 3, 2026, at 8:30 PM. This requirement falls under NAICS code 325414, focusing on the supply of specialized laboratory materials for genomic research.

Biological Product (except Diagnostic) Manufacturing

POSTED

DEADLINE

Supply of xGen Methyl-Seq Library Prep KitsThe National Institutes of Health NHLBI, under the Department of Health and Human Services, is seeking a subcontract for the supply of 12 xGen Methyl-Seq Library Prep Kits, specifically IDT Catalog No. 10009824. These kits are required for methylation profiling research focusing on cell-free DNA from organ transplant patients. To ensure the validity of the research workflow, the kits must be sourced directly from Integrated DNA Technologies or an authorized distributor. This opportunity was posted on August 26, 2026, with a response deadline of September 3, 2026, at 8:30 PM. The contract falls under NAICS code 325414 and is managed through the federal procurement system.

Biological Product (except Diagnostic) Manufacturing

POSTED

DEADLINE

Methylation Sequencing Library Preparation Kits f

Solicitation # 75N98026Q01091

The National Institutes of Health, specifically the National Heart, Lung, and Blood Institute's Laboratory of Applied Precision Omics, is seeking a single-sole source procurement for Integrated DNA Technologies (IDT) methylation sequencing library preparation kits. These products are essential for research on cell-free DNA methylation profiles in organ transplant recipients to identify signatures of organ injury and allograft status. The requirement specifically includes 12 kits of xGen Methyl-Seq Library Prep (Catalog No. 10009824), 6 kits of xGen 2S Plus DNA Library Prep (Catalog No. 10009878), and 1 kit of xGen UDI 10nt Primer Plates 1-16 (Catalog No. 10008054). IDT was selected as the sole source because their workflow is validated to minimize adapter and primer dimer formation, ensuring the data consistency and reproducibility required for the study. This non-competitive acquisition is conducted under FAR Part 13 Simplified Acquisition Procedures, with an estimated total cost of 77,117.11, including shipping and handling. The solicitation was issued on August 26, 2026, with a response deadline of September 3, 2026. Interested parties must provide pricing, delivery timelines, F.O.B. points, and administrative details such as their Unique Entity Identifier and Taxpayer Identification Number. All offerors must maintain active registration in the System for Award Management. The primary point of contact for this procurement is Rashida Ferebee at the NIH office in Bethesda, Maryland.

Biological Product (except Diagnostic) Manufacturing

POSTED

DEADLINE

Pressure Myograph System - Combined Notice of Intent and Sources Sought Notice

Solicitation # PCA-NHLBI-08252

The National Heart, Lung, and Blood Institute intends to negotiate a sole-source purchase order with DMT-USA Inc. for a complete pressure myograph system. This specialized equipment is designed for the ex vivo physiological assessment of small arteries and blood vessels from mouse models, enabling studies on vascular compliance, stiffness, diameter, and functional response. The required system must feature a pressure myograph chamber for vessels ranging from 60 micrometers to 1.2 millimeters, interchangeable cannulas, a longitudinal force transducer, integrated pressure transducers, and a microscope with an integrated camera and infrared illumination. Additionally, the acquisition includes real-time analysis software, all necessary pressure regulation and calibration components, and full delivery, installation, and user training. The government has identified DMT-USA Inc. as the only source capable of providing an integrated system that combines longitudinal force measurement with the necessary vessel-size flexibility and real-time acquisition software. The project will be performed at an NIH facility in Bethesda, Maryland, under NAICS code 339112. While this notice serves as an intent to negotiate a sole-source contract, the government is allowing other responsible sources to submit quotations and technical documentation by the specified deadline to demonstrate their ability to meet all essential requirements. The final decision regarding competition remains at the sole discretion of the government.

Surgical and Medical Instrument Manufacturing

POSTED

DEADLINE